Quick Answer
ONCOLYTICS BIOTECH INC reported Diluted EPS of $0.30 per share (loss) for fiscal year 2025.
ONCOLYTICS BIOTECH INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.30 | +0.0% |
| 2024 | -$0.30 | — |
- ONCOLYTICS BIOTECH INC showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, ONCOLYTICS BIOTECH INC’s diluted eps has grown by 0.0% (from $0.30 per share (loss) to $0.30 per share (loss)).
- The most recent figure is from ONCOLYTICS BIOTECH INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: